Back to BlackRock, Inc. BlackRock, Inc.

DNLIDNLI
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in DENALI THERAPEUTICS INC

BlackRock, Inc. holds 14M shares of DNLI (DENALI THERAPEUTICS INC), worth $360.8M as of 2026-Q2. The position was increased (+7.6% shares). DNLI represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$360.8M

Current Shares

14M

Total Value Change

+$77.1M

Total Shares Change

+106,168

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
14M
+7.6%
$360.8M0.0%$25.72
33
2026-Q1
Increased
13M
+2.5%
$250.3M0.0%$20.02
32
2025-Q4
Increased
12.7M
+3.5%
$209.9M0.0%$16.41
32
2025-Q3
Increased
12.3M
+2.0%
$178.4M0.0%$14.52
31
2025-Q2
Decreased
12.1M
-12.9%
$168.6M0.0%$14.10
0
2025-Q1
Decreased
13.8M
-0.6%
$188.1M0.0%$14.78
0
2024-Q4
New
13.9M
-
$283.7M0.0%$20.24
43

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used